ondansetron
ondansetron is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand name including ondansetron. Available dosage forms: injection, powder, tablet, orally disintegrating.
Drug details
- Generic Name
- ondansetron
- Brand Names
- ondansetron
- Application Number
- ANDA206846
- Sponsor
- Accord Healthcare, Inc.
- NDC Codes
- 7
- Dosage Forms
- INJECTION, POWDER, TABLET, ORALLY DISINTEGRATING
- Routes
- INTRAMUSCULAR, INTRAVENOUS, ORAL
- Active Ingredients
- ONDANSETRON
Indications and Usage
1 INDICATIONS AND USAGE Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 initial and repeat courses of moderately emetogenic cancer chemotherapy radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting. Ondansetron tablets are a 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . (1) nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. (1) nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. (1) postoperative nausea and/or vomiting. (1)